Loading...

Skip Navigation LinksHome > Support Groups > Discussion Messages
Miscellaneous :
General

This support group serves as an information center for other discussions on health topics.

 

Join this Group


 











Loading...

News Comments
Add a topic Recent discussions
Start watching this topic
European Union Rules Out Erbitux for Lung Cancer

The European Union has rejected Erbitux drug for treatment of lung cancer, denting growth prospects for the company’s top-selling oncology treatment.

European regulators were concerned that Erbitux provided only a “modest” benefit to ...Read More

Posted on : Sunday, July 26, 2009 12:00 AM
Add reply       No of replies : 1

Report Abuse

You can help us in removing abusive content or spam.
Your Name
Your Email ID
Subject
Message
(Maximum 3000 Characters)
  
 
Why don't some of these big drug companies trial Low Dose Naltrexone which seems to help many with cancer, is it because it is not a big money maker? It's scandalous that any drug company wants to pump people's veins with dangerous chemicals when Low Dose Nalterxone is around and could be trialled at least as an adjuct to any chemo.........
Replied on Sunday, July 26, 2009 12:00 AM
 


Member Sign In

Remember me
Forgot Password?
Sign up now


Medwonders has 257239 Members and 444 Groups.
Last Updated - Nov 25, 2024 - Designed & Content Managed by Medindia4u.com Pvt. Ltd.
Copyright © 2024 Medindia4u.com Pvt. Ltd. All rights reserved.